Stocks
Allogene Therapeutics (ALLO) FCF/share US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| FCF/share, rub | -1.52 | -1.58 | -1.52 | -1.03 | -0.68 | -0.46 | |||
| Changes by years, y/y, % | +1% | +4% | -3% | -32% | -34% | -14.7% | |||
Allogene Therapeutics. FCF/share, rub
Allogene Therapeutics. FCF/share, changes, %
Allogene Therapeutics (ALLO) FCF/share US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| FCF/share, rub | -0.25 | -0.18 | -0.13 | -0.13 | -0.05 | -0.46 | ||
| Changes by years, y/y, % | -26% | -47% | -37% | -29% | -78% | |||
| Changes by quarters, q/q, % | +40% | -28% | -24% | -7% | -57% | |||
